New Alzheimer’s Drug Delivers Disappointing Results

FRIDAY, June 17, 2022 (HealthDay News)

An experimental

drug called crenezumab did not prevent or slow mental decline in patients with a genetic mutation that greatly raises the risk of developing the disease, the results of a decade-long clinical trial show.

The mutation seen in the few hundred study participants from an extended family in Colombia…